Scarica l'app Stockscreener
140.40
3.15%
4.29
Pre-mercato:
140.50
0.10
+0.07%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Neurocrine Biosciences Inc Borsa (NBIX) Ultime notizie
RBC Raises Price Target on Neurocrine Biosciences to $149 From $144, Keeps Outperform Rating - MarketScreener
Will Neurocrine Biosciences Inc. benefit from current market trendsMarket Growth Review & Weekly Consistent Profit Watchlists - khodrobank.com
Does Neurocrine Biosciences Inc. fit your quant trading modelStop Loss & High Conviction Investment Ideas - Newser
Is Neurocrine Biosciences Inc. a cyclical or defensive stockJuly 2025 Breakouts & Weekly Return Optimization Alerts - khodrobank.com
Will Neurocrine Biosciences Inc. stock go up soonJuly 2025 Volume & Community Consensus Picks - Newser
Neurocrine Biosciences Inc. stock retracement – recovery analysis2025 Stock Rankings & AI Forecasted Stock Moves - Newser
What are Neurocrine Biosciences Inc.’s growth leversPortfolio Gains Summary & AI Powered Buy and Sell Recommendations - khodrobank.com
Is Neurocrine Biosciences Inc. benefiting from interest rate changesStock Surge & Daily Risk Controlled Trade Plans - khodrobank.com
What’s the recovery path for long term holders of Neurocrine Biosciences Inc.July 2025 Analyst Calls & Intraday High Probability Setup Alerts - Newser
Can Neurocrine Biosciences Inc. hit a new high this monthPortfolio Return Summary & Safe Capital Growth Stock Tips - Newser
Will Neurocrine Biosciences Inc. price bounce be sustainablePortfolio Performance Summary & Short-Term High Return Ideas - Newser
Does Neurocrine Biosciences Inc. have pricing powerJuly 2025 Update & Fast Momentum Stock Entry Tips - khodrobank.com
Neurocrine Biosciences Shares Dip 4.09% on Strong Volume Surge to 478th Rank Amid Q2 Earnings Boost - AInvest
Neurocrine at Cantor Global Healthcare Conference: Strategic Insights on Growth - Investing.com
Neurocrine Biosciences' Strategic Position in the CNS Therapeutics Market - AInvest
Transcript : Neurocrine Biosciences, Inc. Presents at Cantor Global Healthcare Conference 2025, Sep-03-2025 01 - MarketScreener
Does Neurocrine Biosciences Inc. qualify in momentum factor screeningJuly 2025 Big Picture & Stepwise Entry and Exit Trade Signals - Newser
Endometriosis Pain Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma Corp, AbbVie/Neurocrine - Barchart.com
What to expect from Neurocrine Biosciences Inc. in the next 30 daysJuly 2025 Final Week & Accurate Buy Signal Alerts - Newser
Is a relief rally coming for Neurocrine Biosciences Inc. holdersMarket Performance Recap & Breakout Confirmation Alerts - Newser
Will Neurocrine Biosciences Inc. stock recover after recent dropBull Run & Weekly Top Gainers Trade List - Newser
Risk vs reward if holding onto Neurocrine Biosciences Inc.July 2025 Volume & Trade Opportunity Analysis Reports - Newser
Custom watchlist performance reports with Neurocrine Biosciences Inc.Portfolio Profit Report & Real-Time Buy Zone Alerts - Newser
Neurocrine Biosciences Inc. stock trendline breakdownIndex Update & Free Technical Confirmation Trade Alerts - Newser
What’s next for Neurocrine Biosciences Inc. stock priceEarnings Performance Report & Stepwise Entry and Exit Trade Signals - Newser
Long term hold vs stop loss in Neurocrine Biosciences Inc.2025 Volatility Report & Real-Time Chart Pattern Alerts - Newser
Will Neurocrine Biosciences Inc. stock hit new highs in YEARQuarterly Market Review & Stock Market Timing Techniques - khodrobank.com
Is Neurocrine Biosciences Inc. showing signs of accumulation2025 Top Gainers & Fast Gaining Stock Reports - Newser
Is Neurocrine Biosciences Inc. being accumulated by smart moneyJuly 2025 Levels & Fast Entry and Exit Trade Plans - khodrobank.com
Technical Bounce Expected in Neurocrine Biosciences Inc. Next Week getLinesFromResByArray error: size == 0 - thegnnews.com
Tick level data insight on Neurocrine Biosciences Inc. volatilityMarket Growth Review & Free Fast Gain Swing Trade Alerts - Newser
Neurocrine Biosciences, Inc. (NBIX) Beats Estimates on Neurology Drug Demand, Expands Payer Access - Yahoo Finance
Neurocrine Biosciences Inc. recovery potential after sell offLayoff News & Real-Time Volume Analysis Alerts - Newser
Is Neurocrine Biosciences Inc. forming a reversal patternVolume Spike & Reliable Price Action Trade Plans - Newser
Understanding Neurocrine Biosciences Inc.’s price movement2025 Technical Patterns & High Yield Stock Recommendations - Newser
Real time social sentiment graph for Neurocrine Biosciences Inc.Jobs Report & Weekly Breakout Opportunity Watchlist - Newser
Tools to monitor Neurocrine Biosciences Inc. recovery probabilityTrade Ideas & AI Enhanced Trading Signals - Newser
Historical volatility pattern of Neurocrine Biosciences Inc. visualizedMarket Performance Recap & Low Drawdown Investment Ideas - Newser
Will Neurocrine Biosciences Inc. outperform small cap indexes2025 Historical Comparison & Real-Time Volume Trigger Notifications - 선데이타임즈
How Neurocrine Biosciences Inc. stock performs during market volatilityMarket Growth Summary & Weekly Setup with High ROI Potential - Newser
How to integrate Neurocrine Biosciences Inc. into portfolio analysis toolsEarnings Miss & Technical Entry and Exit Alerts - Newser
Ranking Neurocrine Biosciences Inc. among high performing stocks via tools2025 Macro Impact & Verified Momentum Stock Ideas - Newser
What Fibonacci levels say about Neurocrine Biosciences Inc. reboundProduct Launch & Verified High Yield Trade Plans - Newser
Real time scanner hits for Neurocrine Biosciences Inc. explainedStop Loss & Weekly High Return Opportunities - Newser
2.09%
0.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):